June Chan, DSc
Professor
Epidemiology & Biostatistics
School of Medicine

Dr. Chan has broad research interests in cancer prevention and public health, in particular what individuals can do to modify their risk of chronic disease, co-morbidity, and death. Her current research is focused on understanding how diet, exercise, other lifestyle factors and genetics contribute to prostate cancer progression, aggressiveness, and death. She is particularly interested in identifying modifiable lifestyle risk factors for prostate cancer progression, and using this information to better understand prostate cancer biology & inform public health recommendations. Her team's clinical and translational research studies aim to identify risk-reduction strategies for men with or at high risk for prostate cancer; evaluate novel molecular markers of prostate cancer aggressiveness that may improve screening, diagnosis, or prognosis of clinically relevant disease; and improve cancer survivorship for the millions of men living with prostate cancer worldwide. She has mentored over 40 students, post-docs, and faculty.

She is PI of a randomized clinical trial examining an exercise intervention among men pursuing active surveillance for prostate cancer; co-PI on a large Dept. of Defense Translational Impact Award focused on improving risk stratification and decision support for men considering active surveillance for low risk prostate cancer; co-leads a national web-based intervention to promote healthy diet & exercise habits among men living with prostate cancer; serves on steering committee for a global clinical trial of exercise among men with metastatic prostate cancer; and is co-investigator on a trial examining a 2 year remotely monitored blended diet and exercise intervention for men undergoing surgery for prostate cancer. She also collaborates with team members on lifestyle interventions and observational research in bladder and colorectal cancer survivors. She and her team are currently launching a new digital cohort study of cancer survivors, called Eat Move Sleep, which is focused on enrolling under-represented individuals with prostate, bladder, or colorectal cancer.

She developed the Diet & Lifestyle sub-study with the Cancer of the Prostate Strategic Research Endeavor (CaPSURE); and has collaborated broadly on other studies focused on prostate cancer, including the Health Professionals Follow-up Study, the Selenium and Vitamin E Cancer Prevention Trial (SELECT), the Prostate Cancer Active Surveillance Study (PASS), and the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group.

Prior Training: 1994 AB Applied Mathematics in Biology, Harvard College 1994-95 Fulbright Scholar, Cancer Epidemiology Unit, Uppsala University, Sweden 1998 ScD Epidemiology, Harvard School of Public Health

Research Interest Keywords: - prostate cancer, cancer prevention, lifestyle risk factors, diet, physical activity, exercise, biomarkers, genetics, epidemiology, medical education, prognostication, public health, risk communication, health education & promotion

Teaching - Course Director, Epid207 Epidemiologic Methods II, UCSF, Epidemiology & Biostatistics - Steering Committee Member, PhD Program in Epidemiology and Translational Science, UCSF

• Previously (2007-2015) - Co-Director, Mechanisms, Methods, & Malignancy (M3), Essential Core Curriculum for Medical Students & Discipline Leader, Epidemiology and Evidence-Based Medicine, Essential Core Curriculum for Medical Students

University Service - Vice Chair, Education, Epidemiology & Biostatistics UCSF - Associate Chair, Clinical Research, Urology, UCSF - Executive Committee Member, Department of Epidemiology & Biostatistics, UCSF - Member, UCSF Helen Diller Family Comprehensive Cancer Center Prostate Cancer Program Leadership Committee

• Platelet factors attenuate inflammation and rescue cognition in ageing.
  Nature 2023 Schroer AB, Ventura PB, Sucharov J, Misra R, Chui MKK, Bieri G, Horowitz AM, Smith LK, Encabo K, Tenggara I, Couthouis J, Gross JD, Chan JM, Luke A, Villeda SA
• Diabetes and incidence of breast cancer and its molecular subtypes: A systematic review and meta-analysis.
  Diabetes/metabolism research and reviews 2023 Xiong F, Dai Q, Zhang S, Bent S, Tahir P, Van Blarigan EL, Kenfield SA, Chan JM, Schmajuk G, Graff RE
• Variety of Fruit and Vegetables and Alcohol Intake are Associated with Gut Microbial Species and Gene Abundance in Colorectal Cancer Survivors.
  The American journal of clinical nutrition 2023 Kyaw TS, Upadhyay V, Tolstykh I, Van Loon K, Laffan A, Stanfield D, Gempis D, Kenfield SA, Chan JM, Piawah S, Atreya CE, Ng K, Venook A, Kidder W, Turnbaugh PJ, Van Blarigan EL
• Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2023 Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA
• Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study.
  British journal of cancer 2023 Xiong F, Wang J, Nierenberg JL, Van Blarigan EL, Kenfield SA, Chan JM, Schmajuk G, Huang CY, Graff RE
• Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study.
  JMIR cancer 2023 Wang EY, Borno HT, Washington Iii SL, Friedlander T, Zhang S, Trejo E, Van Blarigan EL, Chan JM, Shariff-Marco S, Beatty AL, Kenfield SA
• Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality.
  British journal of cancer 2023 Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM
• Nutrition Guidance for Patients on Androgen Deprivation Therapy.
  European urology focus 2023 Kenfield SA, Van Blarigan EL, Graff RE, Borno HT, Macaire G, Chan JM
• Quality of life among colorectal cancer survivors participating in a pilot randomized controlled trial of a web-based dietary intervention with text messages.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2023 Wang L, Langlais C, Kenfield SA, Van Loon K, Laffan A, Atreya CE, Chan JM, Zhang L, Allen IE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP, Van Blarigan EL
• Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II).
  Contemporary clinical trials 2023 Van Blarigan EL, Chan JM, Sanchez A, Zhang L, Winters-Stone K, Liu V, Macaire G, Panchal N, Graff RE, Tenggara I, Luke A, Simko JP, Cooperberg MR, Carroll PR, Kenfield SA
• Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention.
  Urologic oncology 2022 Langlais CS, Chen YH, Van Blarigan EL, Chan JM, Ryan CJ, Zhang L, Borno HT, Newton RU, Luke A, Bang AS, Panchal N, Tenggara I, Schultz B, Lavaki E, Pinto N, Aggarwal R, Friedlander T, Koshkin VS, …
• Optimizing intervention tools to improve nutrition and physical activity for colorectal cancer survivors (Tools To Be Fit): Study protocol of a randomized factorial experiment.
  Contemporary clinical trials 2022 Kenfield SA, Philip EJ, Phillips SM, Meyerhardt JA, Chan JM, Atreya CE, Kim MO, Harris Q, Steiding P, Macaire G, McCullough ML, Piawah S, Johnson WY, Kurttila FA, Lewis WL, Pesmen C, Watson Y, Van …
• Association between adherence to the American Cancer Society Nutrition and Physical Activity Guidelines and stool frequency among colon cancer survivors: a cohort study.
  Journal of cancer survivorship : research and practice 2022 Greenberg AL, Tolstykh IV, Van Loon K, Laffan A, Stanfield D, Steiding P, Kenfield SA, Chan JM, Atreya CE, Piawah S, Kidder W, Venook AP, Van Blarigan EL, Varma MG
• Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula.
  European journal of epidemiology 2022 Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA
• Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 Langlais CS, Graff RE, Van Blarigan EL, Kenfield SA, Neuhaus J, Tabung FK, Cowan JE, Broering JM, Carroll P, Chan JM
• Post-diagnostic health behaviour scores in relation to fatal prostate cancer.
  British journal of cancer 2022 Graff RE, Langlais CS, Van Blarigan EL, Pernar CH, Stampfer MJ, Giovannucci EL, Mucci LA, Chan JM, Kenfield SA
• mHealth Interventions to Promote a Healthy Diet and Physical Activity among Cancer Survivors: A Systematic Review of Randomized Controlled Trials.
  Cancers 2022 Wang L, Langlais CS, Kenfield SA, Chan JM, Graff RE, Allen IE, Atreya CE, Van Blarigan EL
• Association of plant-based diet index with prostate cancer risk.
  The American journal of clinical nutrition 2022 Loeb S, Fu BC, Bauer SR, Pernar CH, Chan JM, Van Blarigan EL, Giovannucci EL, Kenfield SA, Mucci LA
• More evidence that physical activity is beneficial for prostate cancer.
  Prostate cancer and prostatic diseases 2022 Kenfield SA, Chan JM
• Quality of life of colorectal cancer survivors participating in a pilot randomized controlled trial of physical activity trackers and daily text messages.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya C, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP, Van Blarigan EL
• Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II).
  JMIR cancer 2022 Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K
• Association between exposure to radioactive iodine after the Chernobyl accident and thyroid volume in Belarus 10-15 years later.
  Environmental health : a global access science source 2022 Chirikova E, McConnell RJ, O'Kane P, Yauseyenka V, Little MP, Minenko V, Drozdovitch V, Veyalkin I, Hatch M, Chan JM, Huang CY, Mabuchi K, Cahoon EK, Rozhko A, Zablotska LB
• Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized Trial.
  Integrative cancer therapies 2022 Langlais CS, Chen YH, Van Blarigan EL, Kenfield SA, Kessler ER, Daniel K, Ramsdill JW, Beer TM, Graff RE, Paich K, Chan JM, Winters-Stone KM
• Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
  HGG advances 2021 Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N,…
• Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer.
  Cancer medicine 2021 Kenfield SA, Van Blarigan EL, Panchal N, Bang A, Zhang L, Graff RE, Chen YH, Ryan CJ, Luke A, Newton RU, Tenggara I, Schultz B, Wang E, Lavaki E, Zuniga K, Pinto N, Borno H, Aggarwal R, Friedlander T,…
• Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.
  The Journal of urology 2021 Cooley LF, Emeka AA, Meyers TJ, Cooper PR, Lin DW, Finelli A, Eastham JA, Logothetis CJ, Marks LS, Vesprini D, Goldenberg SL, Higano CS, Pavlovich CP, Chan JM, Morgan TM, Klein EA, Barocas DA, Loeb S,…
• Reply by Authors.
  The Journal of urology 2021 Cooley LF, Emeka AA, Meyers TJ, Cooper PR, Lin DW, Finelli A, Eastham JA, Logothetis CJ, Marks LS, Vesprini D, Goldenberg SL, Higano CS, Pavlovich CP, Chan JM, Morgan TM, Klein EA, Barocas DA, Loeb S,…
• A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study.
  Urologic oncology 2021 Pollock Y, Zhang L, Kenfield SA, Van Blarigan EL, Rodvelt T, Rabow M, Macaire G, Weinberg R, Topp K, Friedlander T, Lin A, Fong L, Kim W, Ma B, Hough J, Lee M, Paciorek A, Ryan CJ, Chan JM, Small E, …
• Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.
  JCO precision oncology 2021 Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Kageyama R, Wells DK, Chan JM, Friedlander T, Aggarwal R, Paris PL, Feng F, Carroll PR, Witte JS
• Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history.
  Cancer causes & control : CCC 2021 Langlais CS, Chan JM, Kenfield SA, Cowan JE, Graff RE, Broering JM, Carroll P, Van Blarigan EL
• Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter.
  The Journal of urology 2021 Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ
• Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality.
  Current oncology reports 2021 Langlais CS, Graff RE, Van Blarigan EL, Palmer NR, Washington SL, Chan JM, Kenfield SA
• Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
  Scientific reports 2021 Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Chu C, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Chan JM, Friedlander T, Wyatt AW, Aggarwal R, Paris PL, Carroll PR, Feng F, Witte JS
• Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial.
  Journal of medical Internet research 2020 Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM
• Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study.
  JMIR cancer 2020 Wang EY, Graff RE, Chan JM, Langlais CS, Broering JM, Ramsdill JW, Kessler ER, Winters-Stone KM, Van Blarigan EL, Kenfield SA
• Opportunities and challenges for research on low-carbohydrate diets in prostate cancer.
  Nature reviews. Urology 2020 Langlais CS, Chan JM
• The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer.
  Journal of racial and ethnic health disparities 2020 Zuniga KB, Borno H, Chan JM, Van Blarigan EL, Friedlander TW, Wang S, Zhang L, Kenfield SA
• Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Van Blarigan EL, Kenfield SA, Chan JM, Van Loon K, Paciorek A, Zhang L, Chan H, Savoie MB, Bocobo AG, Liu VN, Wong LX, Laffan A, Atreya CE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP
• Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.
  Cancer medicine 2019 Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR
• A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance.
  The Journal of urology 2019 Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR
• Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer.
  The Journal of urology 2019 Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR
• Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.
  The Journal of urology 2019 Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM
• Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM
• Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.
  Prostate cancer and prostatic diseases 2019 Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR
• Diet and lifestyle considerations for patients with prostate cancer.
  Urologic oncology 2019 Zuniga KB, Chan JM, Ryan CJ, Kenfield SA
• Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Downer MK, Kenfield SA, Stampfer MJ, Wilson KM, Dickerman BA, Giovannucci EL, Rimm EB, Wang M, Mucci LA, Willett WC, Chan JM, Van Blarigan EL
• The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.
  International journal of cancer 2019 Watts EL, Perez-Cornago A, Appleby PN, Albanes D, Ardanaz E, Black A, Bueno-de-Mesquita HB, Chan JM, Chen C, Chubb SAP, Cook MB, Deschasaux M, Donovan JL, English DR, Flicker L, Freedman ND, Galan P, …
• Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial.
  BMC cancer 2019 Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP
• The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
  Journal of the National Cancer Institute 2019 Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, …
• Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance.
  The Journal of urology 2019 Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR
• Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer.
  European urology 2019 Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM
• Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.
  Carcinogenesis 2018 Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M…
• Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial.
  JMIR research protocols 2018 Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM
• A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
  Cancer research 2018 Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, …
• Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.
  European urology 2018 Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, …
• Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.
  European urology oncology 2018 Downer MK, Allard CB, Preston MA, Wilson KM, Kenfield SA, Chan JM, Mucci LA, Giovannucci E, Stampfer MJ
• Association of Statin Use With Overall and Cancer Survival.
  JAMA oncology 2018 Chan JM, Kenfield SA, Platz EA
• The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.
  European urology 2018 Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E…
• Increasing Physical Activity in Mothers Using Video Exercise Groups and Exercise Mobile Apps: Randomized Controlled Trial.
  Journal of medical Internet research 2018 Mascarenhas MN, Chan JM, Vittinghoff E, Van Blarigan EL, Hecht F
• Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol.
  BMJ open 2018 Newton RU, Kenfield SA, Hart NH, Chan JM, Courneya KS, Catto J, Finn SP, Greenwood R, Hughes DC, Mucci L, Plymate SR, Praet SFE, Guinan EM, Van Blarigan EL, Casey O, Buzza M, Gledhill S, Zhang L, …
• Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.
  PloS one 2017 Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, …
• Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study.
  The Prostate 2017 Bauer SR, Van Blarigan EL, Stampfer MJ, Chan JM, Kenfield SA
• Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).
  The Prostate 2017 Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM
• Epidemiology of prostate cancer.
  World journal of urology 2017 Cooperberg MR, Chan JM
• The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study.
  JMIR cancer 2017 Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM
• Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy.
  The Prostate 2016 Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP
• Prostate cancer progression and mortality: a review of diet and lifestyle factors.
  World journal of urology 2016 Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA
• Trends in Biometric Health Indices Within an Employer-Sponsored Wellness Program With Outcome-Based Incentives.
  American journal of health promotion : AJHP 2016 Fu PL, Bradley KL, Viswanathan S, Chan JM, Stampfer M
• Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 Chan JM, Darke AK, Penney KL, Tangen CM, Goodman PJ, Lee GM, Sun T, Peisch S, Tinianow AM, Rae JM, Klein EA, Thompson IM, Kantoff PW, Mucci LA
• Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.
  The Journal of molecular diagnostics : JMD 2016 Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP
• A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk.
  Cancer research 2016 Travis RC, Appleby PN, Martin RM, Holly JMP, Albanes D, Black A, Bueno-de-Mesquita HBA, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL,…
• Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.
  Urology 2015 Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ
• Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.
  The Prostate 2015 Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL
• Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer.
  Journal of the National Cancer Institute 2015 Kenfield SA, Batista JL, Jahn JL, Downer MK, Van Blarigan EL, Sesso HD, Giovannucci EL, Stampfer MJ, Chan JM
• The Molecular Taxonomy of Primary Prostate Cancer.
  Cell 2015 Cancer Genome Atlas Research Network
• Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
  The American journal of clinical nutrition 2015 Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, Giles GG, Giovannucci E, Goodman …
• Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study.
  Cancer prevention research (Philadelphia, Pa.) 2015 Van Blarigan EL, Gerstenberger JP, Kenfield SA, Giovannucci EL, Stampfer MJ, Jones LW, Clinton SK, Chan JM, Mucci LA
• Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Chan JM, Kenfield SA, Paciorek A, Platz EA, Giovannucci EL, Stampfer MJ
• Fat intake after prostate cancer diagnosis and mortality in the Physicians' Health Study.
  Cancer causes & control : CCC 2015 Van Blarigan EL, Kenfield SA, Yang M, Sesso HD, Ma J, Stampfer MJ, Chan JM, Chavarro JE
• Patterns of Local Failure following Radiation Therapy for Prostate Cancer.
  The Journal of urology 2015 Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR
• Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study.
  Journal of cancer survivorship : research and practice 2015 Phillips SM, Stampfer MJ, Chan JM, Giovannucci EL, Kenfield SA
• Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study.
  European journal of cancer (Oxford, England : 1990) 2015 Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA
• Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
  Human genetics 2015 Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, Jeong S, Fontham ET, …
• GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis.
  Clinical genitourinary cancer 2015 Margalit DN, Jordahl KM, Werner L, Wang X, Gwo-Shu Lee M, Penney KL, Batista JL, Martin NE, Chan JM, Kantoff PW, Stampfer MJ, Nguyen PL, Mucci LA
• Hair, hormones, and high-risk prostate cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Ryan CJ, Chan JM
• Selenium supplementation and prostate cancer mortality.
  Journal of the National Cancer Institute 2014 Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, L Giovannucci E, Chan JM
• Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
  The Prostate 2014 Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan JM
• Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.
  The Journal of urology 2014 Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR
• Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
  European urology 2014 Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR
• A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
  European urology 2014 Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, …
• What should we tell prostate cancer patients about (secondary) prevention?
  Current opinion in urology 2014 Chan JM, Van Blarigan EL, Kenfield SA
• Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014 Van Blarigan EL, Ma J, Kenfield SA, Stampfer MJ, Sesso HD, Giovannucci EL, Witte JS, Erdman JW, Chan JM, Penney KL
• Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
  BJU international 2014 Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR
• Physical activity and prostate gene expression in men with low-risk prostate cancer.
  Cancer causes & control : CCC 2014 Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM
• Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer.
  European urology 2013 Jones LW, Hornsby WE, Freedland SJ, Lane A, West MJ, Moul JW, Ferrandino MN, Allen JD, Kenjale AA, Thomas SM, Herndon JE, Koontz BF, Chan JM, Khouri MG, Douglas PS, Eves ND
• Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™.
  The Journal of urology 2013 Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan JM
• Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.
  The Lancet. Oncology 2013 Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJM, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH
• Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.
  European urology 2013 Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR
• Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
  The Prostate 2013 Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan JM
• Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study.
  European urology 2013 Kenfield SA, DuPre N, Richman EL, Stampfer MJ, Chan JM, Giovannucci EL
• Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality.
  JAMA internal medicine 2013 Richman EL, Kenfield SA, Chavarro JE, Stampfer MJ, Giovannucci EL, Willett WC, Chan JM
• Active surveillance: does serial prostate biopsy increase histological inflammation?
  Prostate cancer and prostatic diseases 2013 Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll PR
• A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
  Advances in anatomic pathology 2013 Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, …
• Dietary patterns and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area.
  Nutrition and cancer 2013 Chan JM, Gong Z, Holly EA, Bracci PM
• Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
  Cancer prevention research (Philadelphia, Pa.) 2012 Dhillon PK, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM
• Choline intake and risk of lethal prostate cancer: incidence and survival.
  The American journal of clinical nutrition 2012 Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Zeisel SH, Willett WC, Chan JM
• Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Choe KS, Cowan JE, Chan JM, Carroll PR, D'Amico AV, Liauw SL
• Statin use and risk of prostate cancer in the prospective Osteoporotic Fractures in Men (MrOS) Study.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 Chan JM, Litwack-Harrison S, Bauer SR, Daniels NA, Wilt TJ, Shannon J, Bauer DC
• Editorial comment.
  Urology 2012 Cooperberg MR, Chan JM
• PSA screening: determinants of primary-care physician practice patterns.
  Prostate cancer and prostatic diseases 2012 Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM
• Selenium and prostate cancer: the puzzle isn't finished yet.
  The American journal of clinical nutrition 2012 Richman EL, Chan JM
• Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK
• Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 Pettersson A, Kasperzyk JL, Kenfield SA, Richman EL, Chan JM, Willett WC, Stampfer MJ, Mucci LA, Giovannucci EL
• PSA screening: determinants of primary-care physician practice patterns.
  Prostate cancer and prostatic diseases 2011 Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM
• Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival.
  Cancer prevention research (Philadelphia, Pa.) 2011 Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM
• Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation.
  PloS one 2011 Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM
• Vegetable and fruit intake after diagnosis and risk of prostate cancer progression.
  International journal of cancer 2011 Richman EL, Carroll PR, Chan JM
• Smoking and prostate cancer survival and recurrence.
  JAMA 2011 Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E
• Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer?
  Urologic oncology 2011 Aggarwal RR, Ryan CJ, Chan JM
• Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor.
  Cancer research 2011 Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM
• Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM
• Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
  BJU international 2011 Abe M, Xie W, Regan MM, King IB, Stampfer MJ, Kantoff PW, Oh WK, Chan JM
• Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer.
  Cancer causes & control : CCC 2010 Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR
• Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area.
  International journal of cancer 2010 Gong Z, Holly EA, Wang F, Chan JM, Bracci PM
• Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE.
  BJU international 2010 Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV
• Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
  Urologic oncology 2010 Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan JM
• Increased risk of high-grade prostate cancer among infertile men.
  Cancer 2010 Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll PR, Smith JF, Eisenberg ML, Van Den Eeden SK, Croughan MS
• Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.
  Cancer causes & control : CCC 2010 Barnett CM, Nielson CM, Shannon J, Chan JM, Shikany JM, Bauer DC, Hoffman AR, Barrett-Connor E, Orwoll E, Beer TM
• Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression.
  The American journal of clinical nutrition 2009 Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM
• Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Shappley WV, Kenfield SA, Kasperzyk JL, Qiu W, Stampfer MJ, Sanda MG, Chan JM
• Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW
• Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study.
  Cancer causes & control : CCC 2009 Chan JM, Wang F, Holly EA
• Increased risk of testicular germ cell cancer among infertile men.
  Archives of internal medicine 2009 Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ
• The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Farhat GN, Taioli E, Cauley JA, Zmuda JM, Orwoll E, Bauer DC, Wilt TJ, Hoffman AR, Beer TM, Shikany JM, Daniels N, Chan J, Fink HA, Barrett-Connor E, Parsons JK, Bunker CH, Osteoporotic Fractures in …
• Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
  Annals of internal medicine 2008 Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, …
• No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk.
  The Prostate 2008 Fall K, Stark JR, Mucci LA, Chan J, Stampfer MJ, Kurth T, Febbo PG, Kantoff P, Ma J
• Active surveillance for early-stage prostate cancer: review of the current literature.
  Cancer 2008 Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll PR
• Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
  Journal of the National Cancer Institute 2008 Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ
• Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area, California.
  American journal of epidemiology 2007 Chan JM, Wang F, Holly EA
• Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California.
  Cancer causes & control : CCC 2007 Chan JM, Wang F, Holly EA
• Development of a meat frequency questionnaire for use in diet and cancer studies.
  Journal of the American Dietetic Association 2007 Keating GA, Bogen KT, Chan JM
• Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer.
  Current treatment options in oncology 2007 Kenfield SA, Chang ST, Chan JM
• Prostate cancer.
  The Journal of urology 2007 Penson DF, Chan JM, Urologic Diseases in America Project
• Demographic factors associated with the diet quality of older US men: baseline data from the Osteoporotic Fractures in Men (MrOS) study.
  Public health nutrition 2007 Shannon J, Shikany JM, Barrett-Connor E, Marshall LM, Bunker CH, Chan JM, Stone KL, Orwoll E, Osteoporotic Fractures in Men (MrOS) Research Group
• Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
  Urologic oncology 2007 Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID
• Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans.
  Prostate cancer and prostatic diseases 2007 Bogen KT, Keating GA, Chan JM, Paine LJ, Simms EL, Nelson DO, Holly EA
• Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE.
  Urology 2006 Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR, CaPSURE Investigators
• The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs.
  Hematology/oncology clinics of North America 2006 Chan JM, Feraco A, Shuman M, Hernández-Díaz S
• Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States).
  Cancer causes & control : CCC 2006 Chan JM, Holick CN, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Giovannucci EL
• Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
  Urology 2005 Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR
• Role of diet in prostate cancer development and progression.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Chan JM, Gann PH, Giovannucci EL
• Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
  Urology 2005 Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ
• History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).
  Cancer causes & control : CCC 2005 Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR
• Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Chan JM, Wang F, Holly EA
• The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE).
  The Journal of urology 2005 Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane CJ
• Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.
  Carcinogenesis 2005 Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris …
• Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer.
  Clinical prostate cancer 2005 Sheriff SK, Shohara RA, Dumican SB, Small EJ, Carroll PR, Chan JM
• Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
  The Journal of urology 2005 Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR
• Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment.
  The Journal of urology 2004 Carroll PR, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW
• The relative impact and future burden of prostate cancer in the United States.
  The Journal of urology 2004 Chan JM, Jou RM, Carroll PR
• A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 Ewart-Toland A, Chan JM, Yuan J, Balmain A, Ma J
• A prospective study on supplemental vitamin e intake and risk of colon cancer in women and men.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Wu K, Willett WC, Chan JM, Fuchs CS, Colditz GA, Rimm EB, Giovannucci EL
• Aspirin use in relation to risk of prostate cancer.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Leitzmann MF, Stampfer MJ, Ma J, Chan JM, Colditz GA, Willett WC, Giovannucci E
• Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.
  Journal of the National Cancer Institute 2002 Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E
• Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study.
  The American journal of clinical nutrition 2001 Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL
• Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
  Journal of the National Cancer Institute 2001 Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, Willett W, Stampfer MJ
• Dairy products, calcium, and vitamin D and risk of prostate cancer.
  Epidemiologic reviews 2001 Chan JM, Giovannucci EL
• Vegetables, fruits, associated micronutrients, and risk of prostate cancer.
  Epidemiologic reviews 2001 Chan JM, Giovannucci EL
• Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland).
  Cancer causes & control : CCC 2000 Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J, Albanes D, Virtamo J
• A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men.
  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000 Ma J, Pollak M, Giovannucci E, Chan JM, Tao Y, Hennekens C, Stampfer MJ
• Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies.
  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2000 Chan JM, Stampfer MJ, Giovannucci E, Ma J, Pollak M
• Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999 Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL
• Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
  Journal of the National Cancer Institute 1999 Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ
• The role of diabetes mellitus in the aetiology of renal cell cancer.
  Diabetologia 1999 Lindblad P, Chow WH, Chan J, Bergström A, Wolk A, Gridley G, McLaughlin JK, Nyrén O, Adami HO
• Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden)
  Cancer causes & control : CCC 1998 Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk A
• What causes prostate cancer? A brief summary of the epidemiology.
  Seminars in cancer biology 1998 Chan JM, Stampfer MJ, Giovannucci EL
• Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.
  Science (New York, N.Y.) 1998 Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M
• Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men.
  BMJ (Clinical research ed.) 1995 Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC
• Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.
  Diabetes care 1994 Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC